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 PREFACE 
 
 
UISCE, the Union for Improved Services, Communication, and Education is a group made 
up of users, ex-users, and professionals who believe that the voice of the drug user is 
integral in the development of drug policy and in realising an effective treatment response. 
 
UISCE was formed as a result of a North Inner-City Drugs Task Force (NICDTF) initiative. 
THE NICDTF is one of 14 local Drugs Task Forces in Ireland overseen by the National 
Drugs Strategy Team. Set up in the aftermath of the murder of journalist Veronica Guerin, 
the Task Forces provide community based responses to tackling the growing drug problem 
in the areas most affected by drug use.  The Task Forces consist of representatives from 
the statutory, voluntary, and community sectors. Many of them have also evolved to include 
political representatives. 
 
The NICDTF recognised that drug users are also part of the community and, as recipients 
of the services, should be involved in the assessment and policy-making processes. A seat 
was reserved on the Task Force for a representative who would bring the concerns and 
issues of service users to the table. It was envisaged that this position would be held by 
someone who had been, or was currently, a drug service user. As a result, the Service 
Users Forum was formed which was the precursor to UISCE.  
 
In 1999, UISCE constructed a questionnaire in order to ascertain the issues that were of 
most concern to drug users. The questionnaire was long and covered a broad range of 
issues such as homelessness, prejudice, prison conditions and methadone. It was 
answered by 96 people.  People were overwhelmingly unhappy about the government’s 
Methadone Protocol, especially the introduction of Methadone DTF to replace Physeptone. 
It emerged during this research process that the use of other drugs had increased 
dramatically since the Protocol, particularly benzodiazepines (prescription drugs) and 
alcohol.  
These, and other issues which arose, prompted UISCE to conduct a second more in depth 
survey. 
 
UISCE is not a professional medical body. This report reflects the opinions and 
observations of north inner-city service users who contributed, by interview or through 
focus groups, to this action research. 
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1. INTRODUCTION 
 
Methadone is the drug on which the treatment of heroin addiction is based. At present 
approximately 5,000 people in Dublin are being treated with this drug. Where did it come 
from and how did it find its way into treatment? Why is it used instead of other opiates? 
How successful is methadone? This report hopes to answer some of these questions and 
to also look at the quality of the treatment that accompanies it.  
   
1.1  A Brief History of Drugs 
 
There is nothing new about drug use. It has always been a part of human nature to get high 
or to alter states of consciousness. Many ancient records refer to drug use of one kind or 
another such as cannabis, alcohol, coca, tobacco, or opium.  
 
Of all the drugs known to humans, the one that has caused most concern is opium and its 
derivatives. Opium, referred to as the ‘joy plant’ in Sumerian texts 4000 years old, is the 
milk or sap of a particular type of poppy, Papaver Somniferum, which grows in the Middle 
East and Asia. Although many people used opium simply to get ‘stoned’ it was also widely 
used throughout the world as a medicine; it was used as a painkiller, a sleeping draught, 
and as a cough medicine. 
 
The next link in the chain that leads from opium to methadone is the discovery of morphine. 
This happened in Germany in 1804 when a young chemist called F.W. Serturner managed 
to isolate the main ingredient of opium and name it morphine. Morphine was deemed to be 
ten times the strength of opium and it quickly found its way into mainstream medicine as a 
powerful painkiller. In 1843 the syringe was invented by Alexander Woodin, allowing drugs 
to be injected directly into a vein, and this increased the potency of morphine even more. At 
the time, morphine could be bought without a prescription at any drug store and there was 
nothing illegal about using it.  
 
In London in 1874 a chemist named C.R. Alderwright boiled a sample of morphine with 
acetic anhydride, a chemical similar to ordinary vinegar and produced a compound which 
he called diamorphine. Four years later in Germany another chemist named Heinrich 
Dresser endorsed this drug for the treatment of coughs, chest pains, pneumonia, TB, and 
pain relief. He also gave it the name ‘heroin’. 
 
 
 
1.1.1 Drug Laws 
 
Efforts to control the production and supply of opiates began to pick up steam in 1909 when 
an international conference on the control of opiates was held in Shangai. Three years later 
at the Hague Convention it was agreed that opium smoking should be outlawed and that 
narcotics should be manufactured for medical use only. In 1914 the Harrison Narcotic Act 
was passed in the United States. The major thrust of this Act was to take the sale of 
narcotics away from grocery stores and other common peddlers and place it in the hands of 
the medical profession. From this point on, controlled drugs could only be obtained with a 
doctor’s prescription and a doctor could only prescribe when acting in good faith or in the 
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legitimate practice of his or her profession. In essence, American doctors were forbidden to 
treat addicts by maintaining them on controlled drugs. 
 
Years later, a British doctor, J.H. Willis, Consultant Psychiatrist in Drug Dependence wrote, 
“This was a formidable piece of legislation which had the effect of virtually outlawing 
anyone who was an opiate addict; thus the attitude of the public and the medical profession 
became a negative one directed towards the addict who was automatically identified as a 
criminal”.1 
 
Britain soon followed suit, amending the Dangerous Drugs Act of 1920 to include opiates, 
stating that possession and use of drugs were to be limited to doctors prescribing such 
drugs only as far as may be necessary for “the exercise of his (sic) profession.”  
 
However, a conflict soon arose over what this phrase meant. In 1924, the Minister of Health 
appointed a group of leading physicians headed by Sir Humphrey Rolleston, president of 
the Royal College of Physicians, to advise the government as to what the legitimate 
practice of medicine was in relation to drug dependence.  The report was delivered in 1926 
and determined addiction to be a manifestation of a disease rather than pure indulgence. In 
1958, the Minister of Health appointed a committee to review the Rolleston Report. Chaired 
by Russell Brain, the report recommended no changes to the Rolleston guidelines. 
However, as the number of addicts grew, a second report of the Brain Committee was 
issued in 1965, finding an increase in the number of addicts who were not using opiates for 
therapeutic purposes. Recommending that heroin and cocaine be categorised as restricted 
drugs, the Brain Committee also initiated the setting up of specific treatment centres for 
addicts in 1968. 
 
 
 
 
                                                
1.1.2 Methadone 
 
Following the Second World War, heroin use in US cities again attracted public attention 
and new laws mandating more severe penalties for sale or possession of opiates were 
passed. Despite this, heroin use did not disappear and crime rates continued to grow. As it 
was believed that a lot of this crime was due to addicts who used the money to buy heroin, 
there was an increasing interest in finding a way to prevent and treat addiction. 
 
Because of the Harrison Act, US law forbade doctors to treat addicts with drugs. Between 
1920 and 1945, 25,000 doctors were prosecuted for prescribing to addicts. The usual way 
to treat addicts was a hospitalised de-tox, but studies showed that almost all addicts 
relapsed within the first year after release. Doctors Vincent Dole and Marie Nyswander 
introduced the use of oral methadone as a form of treatment in New York City in 1964. 
Methadone is a synthetic drug, first invented in Germany during the Second World War by 
scientists who, having discovered pethedine some years earlier, were developing other 
similar compounds. 
 
This approach was a sharp departure from previous practices and results were consistently 
better than that which had been previously observed. Soon, other doctors began to use oral 
 
1 Willis, J.H. (1969). Drug Dependence: A Study for Nurses and Social Workers, London: Faber and Faber, p.25. 
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methadone in the treatment of heroin addiction. Early reports were almost unanimous in 
finding that those who remained in treatment showed a sharp drop in their use of heroin, a 
marked decrease in criminal activity, and an increase in legitimate employment as 
compared to their behaviour prior to entry into treatment. 
 
Oral methadone has several advantages that made it particularly useful at the time of its 
introduction in the US. The most important is its long duration of action. It was important to 
have a drug that would have a stable level of tolerance so that progressive escalation of 
dosage would be unnecessary. It also seemed important to be able to state that addicts 
derived no euphoria from taking methadone and that large doses produced a blockade of 
the ‘high’ from heroin. Also, because methadone is chemically different from heroin and 
morphine, it was possible, through urinalysis, to demonstrate a decline in the use of heroin 
by addicts on methadone programmes. 
 
 
 
 
 
 
 
 
1.1.3 The Dublin Context 
 
Illicit drug use was virtually unknown in Ireland until the late 1960's. There was no 
organised black market and the supply of heroin was sporadic. The most popular drugs 
among addicts were Diconal, Palfium, and Morphine Sulphate. Users acquired these drugs 
from ‘liberal’ doctors, by forging prescriptions, or by breaking into pharmacies and stealing 
the drugs. 
 
In 1972 drug treatment was "centralised" and any doctor who encountered an addict was 
advised to refer them to the National Drug Advisory and Treatment Centre in Jervis Street. 
The objective of this centre was to promote abstinence and methadone was used mainly 
for gradual detoxification. In rare cases, however, methadone was used over a prolonged 
period of time to maintain addicts and stabilise their condition.  
 
In the late 1970's the number of heroin addicts in the city increased dramatically when 
‘crime lords’ took over the supply of illegal drugs.  However, in the mid-1980's the supply of 
illegal heroin dried up and drug users turned to other drugs, such as Morphine Sulphate 
Tablets (MST’s). Although these tablets were meant for oral consumption, they were often 
crushed and injected, causing abscesses, thrombosis, and occasionally the amputation of 
limbs. Worldwide there were also growing concerns about a ‘new’ virus (HIV) which led to 
AIDS and it had been determined that this virus, along with Hepatitis, could be contracted 
through the sharing of syringes. Needle exchange programs and more methadone 
maintenance programmes were implemented to address growing HIV infection among drug 
users. The 1980’s also saw the formation of Concerned Parents Against Drugs, a 
community based movement that sought to address the drug problem from a community 
perspective. 
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In the early 1990's the use of heroin began to significantly increase in the city and by the 
mid-1990's there was a new epidemic. Thousands of young people began to use heroin 
and some local authority housing complexes became open markets for all kinds of drugs. 
People were injecting openly in public places and injecting equipment was being discarded 
in schools and children's playgrounds, giving rise to fears about children inadvertently 
contracting HIV. Drug related crime was at an all time high and gangland murders were not 
uncommon. From the communities’ perspective it seemed that dealers were openly 
flaunting their wealth and the police appeared to be doing nothing to address the problem. 
Many young people were dying as a result of drug overdoses, drug-related suicide, and 
AIDS related illnesses.  
 
The residents of communities most affected by the problem were outraged and decided to 
take steps to rid their areas of this drug dealing. People were trying to cope with the 
stresses and strains of handling a situation which was out of control and which threatened 
to undermine the social fabric of the community.  The Coalition of Community Against 
Drugs (COCAD) took up the mantle of Concerned Parents Against Drugs.  Neighbourhood 
committees were formed and drug dealers, who were often addicts themselves, were 
sometimes forcibly evicted from their homes. The 1997 Housing Act legitimised evictions by 
allowing Dublin Corporation to evict tenants of drug related ‘anti-social’ behaviour. 
 
As thousands of people marched on Dáil Éireann demanding a response from the 
government, community leaders insisted that the community be involved in any policy 
making process. In 1995, people in the most disadvantaged communities across Dublin city 
were trying to deal with the devastating impact of the drug crisis on their local areas. ICON 
(Inner City Organisations Network) took the initiative of inviting groups to come together to 
a meeting in Liberty Hall to launch a joint campaign on behalf of all the communities 
affected. This was the beginning of the Citywide Drugs Crisis Campaign. The community 
leaders involved in the campaign had learnt from their experiences in the 1980’s 
Concerned Parents movement and knew that, as well as action at local community level, 
their campaign had to be aimed at the policy makers and decision makers. The 
communities most affected by the drugs crisis had to campaign for the right to have a say 
in how drug policies were developed and how resources were allocated. Citywide held a 
number of meetings that looked at the key policy areas of health, education/prevention and 
supply control and produced its first policy document in May 1996. The work of Citywide 
continues to have the dual focus of supporting communities at local level in responding to 
the drugs crisis, while at the same time increasing their involvement and impact in 
developing policy at local, regional, and national level. 
 
The high profile assassination of the investigative journalist Veronica Guerin by alleged 
drug dealers, along with a growing political awareness of the seriousness of the situation, 
led to the creation of community-based Task Forces. These agencies would act as a co-
operative effort between statutory and non-statutory agencies and local communities in 
tackling the drugs crisis.  
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2. BACKGROUND TO RESEARCH 
 
Following the establishment of the working group and management committee, UISCE 
began receiving feedback from drug service users about issues that were of major concern 
to them. This feedback was gleaned through street outreach, public meetings for drug 
users in Liberty Hall, as well as letters to the UISCE Newsletter.  
 
As already mentioned in the Preface, the initial survey that we undertook highlighted many 
issues but clearly showed a high level of dissatisfaction with Methadone DTF provision in 
light of the Methadone Protocol. 
 
The Protocol was introduced by the government in 1998 to streamline drug treatment and 
to address the growing concerns about the methadone ‘black market’. In effect this meant 
that GPs could no longer prescribe methadone unless they ‘signed up’ to the protocol 
procedures. These procedures included limits on methadone patient numbers, centralised 
patient records, and the issuing of Photo ID cards to methadone patients. They also 
guaranteed that no one would have to pay privately to attend a GP for methadone 
treatment. In addition training would be provided for GP’s who were willing to prescribe 
methadone and engage in the protocol. As part of this protocol, Methadone DTF was 
introduced to replace Physeptone which had been deemed by health authorities to be less 
suitable for longer term maintenance purposes. However, our first questionnaire found that 
many drug users found Methadone DTF to be far less effective than Physeptone resulting 
in earlier withdrawal symptoms and an increase in self medication in order to compensate 
for this effect. The issues around the comparison of Methadone DTF (green), to 
Physeptone (brown) came to the fore at a focus group held with drug service users at 
Liberty Hall.  
 
As a result of these growing concerns, UISCE decided to carry out a comprehensive survey 
of drug service users in the city. This survey hoped to systematically research the impact of 
the Protocol on those in drug treatment.  
 
However as with the best laid plans, this process highlighted a much broader and complex 
range of problems faced by clients within drug treatment services. While UISCE did their 
best to confine the parameters of the research, it was clear that respondents were going to 
take full advantage of being asked for their opinion on drug services. The organisation had 
certainly won the confidence of drug service users and as a result many people contacted 
UISCE wanting advice or assistance with problems they were having with their clinics, 
GP’s, and chemists. This ground swell forced UISCE to respond by creating a space where 
people could feel safe to discuss the problems they were having. Focus groups were held 
in Liberty Hall and these were extremely well attended. Many of the issues related to how 
powerless people felt about decisions taken in relation to their drug treatment. While we set 
out to focus on the physiological impact of Methadone DTF, we also gathered extremely 
important additional information and insights from drug service users which we include in 
this report.  
   
 9
3. METHODOLOGY 
 
Information was ascertained through focus groups held at Liberty Hall as well as a brief 
questionnaire2 administered to service users. A unique aspect of the methodology was the 
fact that the focus groups and questionnaires were co-facilitated and designed by drug 
service users. This is in marked contrast to the external evaluation commissioned by the 
Eastern Health Board by Farrell et al 2000.3 From UISCE’s point of view, the omission of 
service users from the research process could be seen as indicative of an invalidation of 
their views. Methadone patients are rarely seen as a consumer group whose expectations 
and experiences need to be taken into account when designing and operating treatment 
programmes.  
 
With this in mind, UISCE undertook to ascertain the level of satisfaction with Methadone 
DTF, as compared to Physeptone; and also to gauge the change in usage patterns of other 
drugs over a three-year period, corresponding with the introduction of the Protocol.  
Provision was also made for service users to make comments on the stated questions as 
well as any additional comments they might wish to make. 
 
In agreeing a methodology for the research, UISCE decided to keep the survey as brief as 
possible to facilitate its implementation in a variety of settings. Members of UISCE carried 
out the questionnaire in drug treatment centres, in restaurants, in individuals’ homes, and 
on the street.  
 
The questionnaire first ascertained the age and gender of respondents, the brand of 
Methadone they were being prescribed, and the length of time the respondents had been 
on Methadone DTF.  Respondents were then asked to compare Methadone DTF to 
Physeptone and to state any differences they might have perceived. Finally, respondents 
were asked to state whether their use of individual drugs had increased, decreased, or 
stayed the same after the introduction of the Methadone Protocol. 
 
 
 
                                                 
2 See Appendix 1. 
3 O’Farrell, M. et al (2000). External Review of Drug Treatment Services for the Eastern Health Board, National 
Addiction Centre, London: Institute of Psychiatry.  In this research, informants were “key policy makers, teams and 
individuals, including GP co-ordinators, Consultant Psychiatrists, Area Managers, Counsellors, Education Officers, 
Outreach Workers, Nurses, Voluntary Sector Agencies and Individuals”  (p.2). 
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4. FINDINGS OF QUESTIONNAIRE 
 
A total of 214 people responded to the questionnaire and 53% (n=113) were male and 47% 
(n=101) were female. The respondents ranged in age from 19 years to 49 years with the 
average age being 30.5 years. Respondents had been in receipt of Methadone DTF for an 
average of 8.5 years. 
 
 
While 0.5% (n=1) of service users were being prescribed the Glaxo brand of Methadone, 
9% (n=19) were being prescribed Martindale, and the majority (77%, n=165) were being 
prescribed Pinewood. 14% (n= 29) of service users did not know what brand of Methadone 
they were being prescribed. (See Fig 1) 
 
 
 
Fig 1  
Current Brand of Methadone (No of Respondents)
1
165
19
29
Glaxo
Pinewood
Martindale
Don't know
 
 
 
 
When comparing Methadone DTF to Physeptone, only 4% (n=9) of service users felt DTF 
was better than Physeptone. When UISCE explored this further, the only reason given for 
this preference was that Methadone DTF was less damaging to teeth than Physeptone.4 
 
                                                 
4 Interestingly some people who are maintained on Methadone DTF and who have never used Physeptone claim that 
their teeth are decaying despite good oral hygiene care. This would be worth further study. 
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The majority of respondents (88%, n=189) felt that Methadone DTF was not as effective as 
Physeptone while 8% (n=16) felt that they were both equally effective. (See Fig 2)  
Respondents reported the following reasons for their belief that Methadone DTF was less 
effective than Physeptone: 
 
 Difficulty sleeping with Methadone DTF. 
 Waking up early and experiencing withdrawal symptoms. 
 Takes longer to take effect (‘kick in’) than Physeptone. 
 Increases tendency to perspire and feelings of discomfort. 
 Constipation and wind. 
 Weight gain and obesity. 
 
Fig 2 
How does Methadone DTF compare with 
Physeptone?
0 50 100 150 200
No of Service
Users
Not as good
Same
Better
 
 
 
4.1 Perceived Differences Between Methadone DTF and Physeptone 
 
71% (n=152) of respondents felt that Methadone DTF does not stave off withdrawals as 
long as Physeptone. 64% (n=138) stated that Methadone DTF does not provide the 
‘warmth and glow’ of Physeptone and 34% (n=73) stated that Methadone DTF did not 
provide the ‘buzz’ of Physeptone.  
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4.2 Impact on Drug Use 
 
 
Respondents were asked to describe their drug use since the introduction of the Protocol. 
They were asked whether their use of certain drugs had decreased, increased, or remained 
the same. (See Fig 3) 
 
Fig 3 
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As the above chart indicates, there has been a substantial increase in the use of other drugs. The 
percentage increase ranges from 19% (Cannabis) to 75% (Benzodiazepines). Heroin use increased 
by 41%. Poly drug use also increased. (See Fig 4) 
 
Fig 4 
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5. ADDITIONAL CONSULTATION WITH SERVICE                                            
USERS 
 
As already mentioned, focus groups were held with drug service users to feed back initial 
results from the survey findings. However, these groups were also used as an opportunity 
to allow people to voice their concerns about the findings and other aspects of their drug 
treatment programme. The main areas of concern were as follows: 
 
 Problems with the effectiveness of Methadone DTF 
 Attitudes of ‘Protocol’ staff (e.g. GP’s, Pharmacists, and Clinic staff) towards 
drug users 
 Use of medication sanctions 
 Use of chemist/client contracts 
 Urinalysis 
 Privacy issues 
 Feelings of powerlessness in relation to decisions on drug treatment 
 Complaint procedures 
 
 
 
5.1 Problems with Effectiveness of Methadone DTF 
 
It is clear from the survey results that many people experience problems with Methadone 
DTF (see section 4) and that they are self medicating to ease the physical discomforts of 
early withdrawals. The following are a selection of quotes by drug service users taken 
directly from the focus meetings: 
 
 
“I’m scoring more on the streets; I feel the Meth is not holding me” 
 
“By 8 or 9 o’clock in the evening I start to feel sick. I always get Meth in the morning but it is 
not holding me until the next morning” 
 
 “I have taken a lot of tablets since the green; I never have before” 
 
“My alcohol use has increased an awful lot; I’m now drinking every day” 
 
“Since the new Meth was introduced I increased my use of benzos” 
 
“I never sweated when I was on the brown” (Physeptone) 
 
“The Meth they are giving us now takes too long to kick in” 
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5.2       Attitudes of ‘Protocol’ staff (e.g. GPs, Chemists, and Clinic Staff) Towards 
Drug Users. 
 
The  majority of those drug users who attended the focus meetings felt that they were 
‘treated’ very badly by professionals within the drug services. Whether these problems are 
real or perceived it is very clear that the drug treatment services have serious issues to 
consider. Perceptions of a problem can be as damaging and as invidious as any ‘real’ 
problem. 
 
“We’re just a number to them” 
 
“They say jump and you jump” 
 
“They think we’re thick as bricks and scumbags because we want Phy off them” 
 
“We’re dismissed and ignored” 
 
“The chemist is too controlling and disrespectful”  
 
“I had a problem with wind and the doctor was sarcastic” 
 
“I want to be treated as a person, yet I don’t want to be pampered or have them crawling all 
over me” 
 
 
 
 
5.3 Use of Methadone Sanctions 
 
Many of the respondents reported that they had been at the receiving end of medical 
sanctions for what they described as minor infringements of their drug treatment 
programme. UISCE had, during this period, been receiving many requests for advocacy on 
behalf of clients who had had their Methadone dose  reduced for reasons which included 
unsubstantiated allegations, lateness, loitering, and ‘negative’ behaviour.  
 
“For being with someone I lost my takeaway and got strung out again” 
 
“I was seen giving money to somebody and my takeaways were taken away” 
 
“I was hanging around the clinic and I was punished and I lost 10 to 20 mls” 
 
“People have been accused of loitering without seeing video evidence” 
 
“People are convicted on hearsay” 
 
“People that are being cut off medicine feel suicidal and depressed” 
 
  
 15
 
5.4 Use of Chemist/Client Contracts 
 
Some clients obtain their Methadone from chemists in the community. One of the aims of 
the Methadone Protocol was to increase the number of participating chemists to allow for 
more decentralisation of drug treatment. Arguably this would also allow a greater deal of 
flexibility and control for the drug user. However many people reported having bad 
experiences with their local chemists but had no avenue of recourse open to them to 
address these problems. Many people are forced to sign behavioural contracts before they 
will be allowed to receive their Methadone from that particular chemist. UISCE has viewed 
one of these contracts and were concerned to note some of the conditions which had to be 
signed up to before a person could receive his/her Methadone. These included 
guaranteeing that a person receiving methadone would not enter the chemist’s premises 
with another person and that he/she would not talk to any chemist staff. In addition, people 
could not purchase any other item at the time of receiving their Methadone. More 
alarmingly, the contract stated that the Chemist could at any time refuse to dispense 
Methadone without giving a reason.   
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“You’ll sign anything or you can fuck off. Your pride goes with that sometimes” 
 
“There’s nothing for us in the Chemist contract. All chemists are watching their backs” 
 
“I don’t seem to have any rights as a customer” 
 
 
5.5 Urinalysis 
 
As a condition of drug treatment clients are required to provide urine samples when 
requested. These samples are tested for the presence of non-prescribed drugs. The 
urinalysis results can be used as a tool for doctors to decide the amount of Methadone a 
client is prescribed. If, for example, a client’s urine shows positive for the presence of non-
prescribed opiates a doctor may decide to reduce the amount of medication given. This is 
usually deemed to be in the clients’ best interests in order to reduce the risk of overdose. If 
clients refuse or are unable to give a urine sample, this is taken to mean that they have 
non- prescribed opiates in their system and the urine is automatically deemed ‘dirty’. 
However, clients reported that there is a lack of confidence in the urinalysis process with 
many people claiming that they have obtained incorrect results leading them to believe that 
there are flaws in this system. Additionally, respondents reported that they find the process 
of supervised urine collection degrading. 
   
 
“I feel very vulnerable in the clinic and giving a urine is too exposing and undignified” 
 
“It’s horrible the way you have to give a urine. There’s no respect, no dignity, and they don’t 
care” 
 
“If you can’t produce a urine in 15 minutes, it’s put down as a refusal. It’s considered worse 
than dirty” 
 
“I’m after having a baby. I’m being punished for not being able to give a urine” 
 
“After complaining about a doctor’s attitude I had a mysterious, “positive” urine” 
 
 
5.6 Privacy Issues 
 
Given that one has to be registered with the state as a drug user in order to obtain 
treatment, respondents frequently reported feeling quite exposed to scrutiny when 
registering with a drug treatment programme. The personal registration of information 
automatically means that many professionals have access to this information. While 
confidentiality is a key principle within the drug treatment services, the reality for people in 
drug treatment is very different. 
 
 
 
“People are breathalysed in public. There is no confidentiality. People then know you are 
drinking” 
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“Everyone who works in the clinic seems to have access to the files; even the porters and the 
cleaners. Where is the confidentiality?” 
 
“When you are talking to counsellors you are effectively talking to the whole clinic” 
 
“If you are spoken about at weekly staff meetings everyone knows your business when it is 
supposed to be confidential” 
 
“If I have a dirty urine, my doctor threatens to ring the Social Services and have my baby taken 
into care” 
  
 
5.7 Feelings of Powerlessness in Relation to Decisions on Drug Treatment 
 
As the current drug treatment service is structured, there is no client/patient involvement in 
the decision making process. While a few people reported having a healthy relationship 
with their doctors and clinic staff, the majority felt excluded and powerless, leading to 
frustration and apathy on the part of many clients. Those who had a good working 
relationship with their doctor were clearly more confident and empowered and felt a sense 
of control around their drug use. However, those who said they did not have a good 
relationship with their clinicians were clearly upset and angry. 
 
“There’s no continuity of care. I feel undermined all the time” 
 
“There’s a lack of consultation. I’m not being taken seriously” 
 
“We cannot be late but the doctors can” 
 
“Doctors are playing God” 
 
“They are controlling us” 
 
“We are never going to be on the same wavelength as doctors” 
 
“You should be able to be involved in your own treatment plan. It’s an excellent  
way of empowering people” 
 
“I wanted to detox but I got maintenance. Even though I said it to the doctor he didn’t listen” 
 
“I can’t choose my dose. I want more involvement” 
 
 
5.8 Complaints Procedures 
 
There is no current user friendly complaints procedure in place within the drug treatment 
services, although a pilot project is underway in City Clinic (Dublin 1) where a client 
complaints procedure is being piloted. The outcome of this evaluation is due in late 2003. 
Many respondents said that if they complained about their treatment, they felt they would 
be victimised in some way by their clinic, GP, or chemist. Indeed many were unaware that 
they had any right to complain. Consequently, unresolved problems were escalating 
causing tension and frustration for service users. 
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“Methadone stops people complaining. They are afraid of getting sanctioned” 
 
“There should be someone independent to go to with complaints from drug users” 
 
“There should be someone neutral that you can speak to as a person, who doesn’t think you 
are a pain in the arse” 
 
“People complain but there is never any response” 
 
“I complained and got thrown off the Clinic for six months” 
 
“I complained and was told to leave the room by the doctor” 
 
“I had a kidney complaint and couldn’t give a urine. I was sanctioned and I complained but 
there was no result” 
 
“When I complained I was labelled as a trouble-maker” 
 
“If the doctor had less power in docking Phy, I would feel a lot safer about complaining” 
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 6. MEETING WITH THE CONSULTANTS  
 
A decision was made by UISCE to seek a meeting with the senior Consultants in the drug 
treatment services in order to present to them the findings of the research process to date 
and to get feedback from them. In addition to the information already gleaned, a number of 
case studies5 were documented, which gave a more in depth view into the difficulties some 
people were experiencing with their drug treatment programmes. It was the intention of 
UISCE to have another public meeting with drug service users sometime after meeting the 
Consultants to feedback the latter’s responses. 
 
The meeting took place in February 2001 and was attended by members of UISCE and 
three senior members of the drug treatment services. The Consultants had already been 
sent a copy of the research findings including case study documentation and a draft of this 
report; this formed the basis of the meeting. 
 
The Consultants were presented with the range of problems that drug service users 
reported experiencing in their drug treatment programmes. (See Sections 4 and 5).  
 
The following were some of the responses to our questions: 
 
 Pinewood is the most predominantly prescribed of the three brands of Methadone 
DTF. A contract was put out to tender by the health authorities and Pinewood were 
the only company who could meet the criteria outlined in the contract. These criteria 
included meeting the demands of supply and delivery. Cost was not specifically 
mentioned as a factor; no cost comparisons were discussed.  
 
 Regarding the many questions as to why Methadone DTF seemed to be more 
problematic than Physeptone (including ‘holding’ time, excessive sweating, weight 
gain, etc) the Consultants acknowledged there might be a problem with Methadone 
DTF and reported that they had asked Dr. Des Corrigan at the School of Pharmacy, 
Trinity College Dublin to carry out research on their behalf.6  
 
 On the issue of confidentiality, the Consultants stated that the rules are very clear 
and strict. Any breach of confidentiality can lead to dismissal. They stated, however, 
that clients often talked too openly in the waiting areas about their own personal 
problems, thus leading ‘many’ people to be aware of their personal situations. 
 
 On the subject of chemist contracts, the Consultants stated that they had not 
previously seen a contract and were quite surprised when UISCE showed them 
contracts from two different pharmacies. They said that they had no control over 
pharmacies and needed them involved as a way of coping with the increasing 
numbers seeking drug treatment. The same situation also applied to G.P.’s, i.e. the 
Consultants had no say in how G.P.s dealt with service users. UISCE explained that 
many people who had enjoyed a good relationship with clinic staff reported feeling 
isolated and vulnerable when trying to engage with their GP or community 
                                                 
5 Six case studies showing a range of different experiences within drug treatment services were documented (see 
Appendix 2). 
6 To the best of our knowledge, this research is still ongoing. 
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pharmacy. UISCE also asked if there was any follow up on people who had moved 
on to GP treatment to see how they were getting on. The Consultants told UISCE 
that this was due to happen soon and that it would be carried out through group 
sessions rather than on a one-to-one basis. 
 
 The question of how people can make legitimate complaints was addressed by 
UISCE. The Consultants stated there was an existing structure through which clients 
could complain. This involved putting the complaint in writing and having it dealt with 
within the clinic. If the client was not satisfied with the outcome the complaint could 
be taken further. They did accept however that the complaints process took a lot of 
time and effort and that many clients were not articulate or literate enough to see it 
through. Although we did not get around to dealing with the case studies individually, 
the need for an accessible and realistic complaints procedure was present in each 
one. The Consultants felt however that sometimes complaints can be unjustified and 
that a ‘filtering’ system should be put in place if there were to be an advocate. 
 
The issue of dual diagnosis was raised. It has been observed that there are people who 
have both a drug problem and a psychiatric problem. UISCE wanted to know if such people 
are being treated primarily for their drug problem or their psychiatric disorder. The 
Consultants accepted that this was a major problem and that it was difficult to deal with. 
Psychiatric hospitals are often reluctant to treat drug users who suffer from a mental illness 
and GP’s often won’t deal with drug users who also have a psychiatric problem. 
 
UISCE brought to the Consultants’ attention the need for a short stay residential or respite 
house where people could stabilise their drug use or deal with other traumatic issues. The 
Consultants agreed with the need for this and told us they had already obtained a 12 bed 
house in Cherry Orchard. The house is fully prepared but they were unable to recruit staff. 
 
 
6.1       Follow up Meeting with Drug Treatment Service Users in Liberty Hall 
 
A further public meeting was held in April 2001 to feedback to drug service users the 
responses from the consultants and to discuss complaints procedure. Over 100 service 
users attended from all over the city. The outcome of this meeting is reflected in Section 5 
of this report. In addition, and in light of the emerging views of service users throughout this 
entire process, UISCE asked those attending the meeting to describe what their ‘Ideal 
Treatment Centre’ would look like. Their ideas and dreams for this centre are described in 
Section 8.  
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7. CONCLUSIONS AND RECOMMENDATIONS   
 
Although many problems and issues have come to light during the course of this research 
the initial purpose was to look at Methadone DTF and whether or not it meets the needs of 
the people to whom it is prescribed. Unfortunately the evidence clearly shows that 
Methadone DTF is not adequately maintaining people who are opiate addicted. While they 
do go beyond the original scope of this report, the following recommendations are vital for 
the future good practice provision of drug treatment services. Therefore the following is a 
list of conclusions and recommendations emanating not only from the survey results but 
also from the ongoing developmental process which this research report initiated. UISCE 
are calling on the relevant drug treatment services to address these recommendations as a 
matter of urgency.  
 
7.1     Effectiveness of Methadone DTF 
 
88% of those surveyed felt that Methadone DTF was not as effective as Physeptone in 
staving off withdrawals. The impact of this has led to drug users relying on other forms of 
self-medication, i.e. an increase in alcohol, benzodiazepine, cocaine, and even heroin 
usage itself. Service users reported ‘scoring’ more heroin, being sick every day and having 
sleepless nights. It is clearly not in anyone’s interests, neither drug treatment services nor 
service users themselves, to allow this situation to continue. The rationale behind 
prescribed opiate substitutes is to stabilise and establish some sense of normality back in 
drug users’ lives. If Methadone DTF is not effective enough in dealing with opiate addiction, 
the resulting process of self medicating (which is leading to people gaining new addictions 
to other substances whilst engaging in criminal behaviour to raise money to feed these 
addictions) will have a catastrophic effect on drug service users, their families, and the 
community.  
 
Recommendation 1:  An urgent impetus be given to the research currently 
being conducted by Dr. Des Corrigan, Director of the School of Pharmacy, TCD to establish 
the scientific effectiveness of Methadone DTF. 
 
Recommendation 2:  While awaiting the results of the scientific effectiveness of 
Methadone DTF, clients should be allowed to choose the type of opiate substitute that they 
feel is most appropriate to them. This should be done in conjunction with their doctor or 
clinical team. 
 
Recommendation 3:  For those clients who describe themselves as having 
developed poly addictions since the introduction of the Methadone Protocol, resources 
need to be made available to assist them to detoxify and recover from these ‘new’ 
addictions.  
 
7.2        Attitudes of ‘Protocol’ Staff 
 
A large number of those who took part in this research process felt that they were ‘treated’ 
very badly by some professionals and staff within the drug treatment services. This 
included those who were attending GPs and community pharmacies. If people feel that 
they are being looked down on or feel their opinions are dismissed or ignored, this can 
quickly lead to resentment building up, with the result that many people become 
uncooperative in their drug treatment programme. Once again it is not in anyone’s interest 
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to allow situations like this to build up. While UISCE recognises that this is a difficult area to 
comprehensively address (as attitudes and values are very deeply held by all individuals) 
nonetheless there are some recommendations which will help to address these problems.        
 
Recommendation 4:  Training in values and attitudes should be made available 
to all staff working with drug service users. This training should be culturally appropriate 
and specifically focus on the lives of drug users. 
 
Recommendation 5:  Adequate support structures need to be put in place for 
staff who work in drug treatment services. These services are, by their very nature, 
extremely stressful environments to work in and staff need to be supported and supervised 
to enable them to deal with difficult situations.  
 
7.3 Use of Sanctions 
 
Most services include Methadone sanctions as a necessary part of treatment. These 
sanctions include dose reductions, loss of privileges (i.e. loss of ‘take-aways’ at weekends), 
loss of support services within clinics (being put on the Methadone bus), etc. Those 
consulted during this research process say that they are often sanctioned for minor 
transgressions such as being late, being early, loitering, or giving ‘cheek’ to clinic staff. 
Clients report that they have no say in these decisions. The clients must accept this 
sanction without complaint even if they believe they are innocent. 
 
Recommendation 6:  UISCE is calling for the absolute abolishment of the use 
of methadone sanctions as a behavioural control mechanism. Motivational devices, which 
engage the cooperation of clients, should be explored as opposed to using punitive 
measures to coerce cooperation. UISCE recognises that drug treatment staff need to feel 
safe and secure in their work environment. In the case of violent behaviour, or where a 
member of staff is threatened in any way, then the Gardai should be called in to deal with 
this situation.  
 
 
 
 
7.4 Use of Chemist/Client Contracts 
 
As already stated, some clients obtain their Methadone DTF from chemists in the 
community and many people reported having bad experiences with their local chemists. 
The practice of forcing someone to sign a behavioural contract before allowing them to use 
the chemist to collect their medication is questionable. As drug users seem to be the only 
people who are asked to comply with these contracts, issues of discrimination and 
inequality can certainly be raised. 
 
Recommendation 7:  There is a moral obligation on the relevant health 
authorities to ensure that their patients are treated fairly and equitably. Although the 
Consultants did state that they had no control over these situations, UISCE strongly 
recommend that appropriate criteria for involving chemists in the Methadone protocol are 
developed and the situation monitored regularly to ensure that clients are not victimised 
further because of their drug addiction. These negotiations should take into account the 
amount of income that chemists derive from dispensing methadone to their customers. In 
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the event that chemists refuse to engage, clients should be allowed to re-establish their 
treatment programme with their original treatment centre. 
 
7.5      Urinalysis  
 
Urinalysis is the only method currently used to test an individual’s drug consumption. As 
already stated many service users find urinalysis an embarrassing and humiliating 
experience. It is obvious that any procedure which causes this effect on an individual is not 
conducive to a healthy, trusting relationship – essential ingredients for an overall holistic 
approach to drug treatment and recovery.  
 
Recommendation 8: UISCE recommend that other methods of establishing an 
individual’s drug consumption should be investigated, e.g. hair or saliva analysis. Using 
either hair or saliva as a means of analysis would also minimise the possibility of deceptive 
behaviour. It would cut out the ‘middle-man’ role of those who have to supervise the 
collection of urines. The doctor or any other clinician could take hair or saliva samples 
directly from the client.  
 
 
7.6 Privacy Issues 
 
There is a feeling among drug service users that their personal information is circulating 
inappropriately among many professionals and other clients within their clinic setting. The 
system ensures that drug users lives become very public with many other agencies being 
aware of the fact that they are on a treatment programme without them ever having 
disclosed this to them.  Many service users reported that their privacy had been violated 
when they discovered that information went beyond the person they had initially spoken to. 
This may be a necessary way of working within a clinical setting but this must be made 
clear to clients who can then decide what information to give and what to withhold. 
Additionally, many service users are reluctant to engage with counsellors because they 
originally understood a counselling relationship to be absolutely private and confidential. 
Subsequently some service users discovered that issues they discussed were talked about 
at other clinical meetings. While the very sensitive and core issues may not have been 
discussed, the fact that anything was taken out of their conversation and relayed in a more 
public space made people feel insecure about disclosing personal information. 
 
 
Recommendation 9: If the drug treatment centre structure demands a team based 
approach, then it is vital that every service user is made aware of this.  
 
Recommendation 10: UISCE recommends that drug treatment services explore the 
possibility of separating the counselling aspect of a client’s drug treatment programme from 
other clinical aspects. This would help to develop good, healthy, trust based relationships 
between clients and counsellors. 
 
Recommendation 11: General staff in drug treatment centres should make a 
concerted effort to ensure privacy at all times. For example breathalysing people in a 
private space will ensure that other clients will not know that a person has a drink (as well 
as a drug) problem.  
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7.7 Feelings of Powerlessness in Relation to Decisions on Drug Treatment 
 
As already mentioned, the current drug treatment service is structured in such a way that it 
mitigates against client involvement in decision making processes. It stands to reason that 
if people feel they have a sense of control around their treatment programme they will 
respond more positively to treatment suggestions.  
Clients reported that they felt completely powerless in every aspect of their drug treatment. 
This sense of powerlessness only served to further isolate and de-motivate. The 
relationship between doctor and patient is ideally a partnership where both parties need to 
work towards the same goal in order to ensure the best outcome. 
 
 
Recommendation 12: UISCE would recommend that a more equal system of 
partnership between client and drug treatment services be developed. This partnership 
approach would mean that clients can discuss their particular needs with their doctor and a 
‘tailor-made’ treatment programme be devised for them. For example the patient should be 
able to choose between detox and maintenance and they should be able to choose, within 
reason, the dose of methadone suited to their needs – whether that is an increase or a 
decrease. Furthermore, it is important to consider the times when people need to collect 
their medication as some people reported having to give up work because their clinic could 
not facilitate them. 
 
Recommendation 13: It is evident that clients have not been involved in any aspect of 
the provision or evaluation of services. A system of clinic monitoring needs to be devised in 
order to ensure public accountability and good practice. Also clients’ views of the services 
should be regularly ascertained in a manner that guarantees confidentiality in order to 
maximise good quality honest information and feedback.7  
 
7.8 Complaints Procedure 
 
With the exception of the current pilot project in City Clinic, there is no user-friendly 
complaints procedure in place within the drug treatment services. Respondents stated that 
if they complained about their treatment, they felt they would be victimised in some way. 
The system that deals with complaints at the moment is too complicated and has no safety 
net for clients who wish to use it. People are often afraid to make a complaint in case their 
Methadone is reduced. Clients need to have their complaints dealt with fairly quickly but the 
present system takes too long before there is any resolution.  
 
Recommendation 14: There is a need for a simple, transparent complaints procedure 
which ensures client safety.  
 
7.9 Dual Diagnosis 
 
As already mentioned, the issue of Dual Diagnosis is one which is causing much distress to 
many drug service users. The stark reality is that many people who are turned away from 
psychiatric hospitals attempt to commit suicide (some succeed) while others are living lives 
of misery because they remain untreated. It is ironic that a person who is legally prescribed 
                                                 
7 Trinity Court currently have forums so that users of their service can have a voice. The Service Users Forum meets on 
a regular basis with the management team in Trinity Court. The Consultants are hoping that this practice will spread to 
other treatment centres and go someway towards meeting some of the recommendations in this report. 
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Methadone by a state health service can have their medication used against him/her when 
trying to avail of another state health service. 
 
 
Recommendation 15: Senior level discussions need to take place urgently between 
the health authorities as to who is responsible for drug users who present to hospitals with 
psychiatric problems. 
 
7.10 Respite Care 
  
There is a declared need for residential short term respite for people on Methadone who 
need to further stabilise their drug use, for those who need to deal with a positive HIV and 
Hepatitis result, for drug users and their families who need to deal with certain issues away 
from their environment, and for drug users who are returning to the community having been 
in prison. 
 
Recommendation 16: To make renewed and vigorous efforts to attract staff for the 12 
bed unit proposed in Cherry Orchard.  
 
Recommendation 17: To work with drug agencies to look creatively at respite options 
which might be available or which could be developed. 
 
 26
  
8. IDEAL TREATMENT CENTRE 
 
As already mentioned, those drug service users who attended the last meeting in Liberty 
Hall were asked to describe their ‘Ideal Treatment Centre’. As well as the recommendations 
already mentioned, clients felt the following areas were important to be addressed. 
 
8.1      Assessment 
 
There would be shorter waiting lists to facilitate the individual’s readiness to stabilise his/her 
drug use. 
People would have a choice as to whether they want to detox or go onto a maintenance 
programme on entry. 
 
8.2 Counselling 
 
Counsellors would be independent and not be part of the clinical team. This would ensure 
confidentiality as well as ensuring confidence in the client. 
There would be no repercussions for divulging personal information such as drug usage. 
There would be more counsellors available for crisis intervention. 
Counselling would be offered seven days a week and continuity of individual counsellors 
would be assured as much as possible. 
The client would dictate the agenda of each session. 
 
8.3 Urinalysis 
 
Other ways of determining opiate, cocaine, or benzodiazepine usage would be used. The 
terminology used in urinalysis, i.e. clean and dirty, would be changed to negative or 
positive. 
 
8.4 Complaints 
 
There would be an independent body or group to deal fairly and honestly with complaints 
from clients. This body would be made up of workers from outside agencies and Task 
Force representatives. Individuals who become part of this group would be given training in 
the language used by professionals and service users. 
 
 
 
 
 
8.5 Additional Aspects 
 
Clients would be given options to test for Hepatitis and HIV. They would be made fully 
aware of the implications of testing as well as receiving pre- and post test counselling. Test 
results would be confidential and given tactfully and compassionately to clients.There would 
be nutrition and general health classes particularly for people who are HIV or Hepatitis 
positive. 
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Patients would be informed of all facilities in the clinic and given the name of a key worker 
who they could contact if needed.There would be adequate staff to meet the needs of 
clients. Each clinic would have its own dentist for service users.   
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Appendix 1 
(Questionnaire) 
 
UISCE SURVEY ---METHADONE 
 
AGE  _______________years 
 
SEX          Male         Female 
 
How long have you been taking Methadone? ________years 
 
Can you tell us what brand of Methadone you are getting? 
       Glaxo-Phymet 
       Pinewood-Pinadone 
       Martindale 
       Don't Know 
 
IF ON METHADONE FOR MORE THAN TWO YEARS: 
Compared to the old brown methadone (Physeptone), do you think the new green Methadone is: 
       Better 
       The Same 
       Not as good 
What would you say is the main difference for you,  
between green and brown methadone? 
       The Taste 
       The Texture 
       The Amount of Liquid 
       Holds me Longer 
       The Buzz 
       Warmth/Glow 
  
Anything Else? 
_______________________________________________________________________ 
_________________________________________________________________________________
_____________________________________________________________  
 
 
Since the introduction of green Methadone about three years ago, can you tell us whether your use of the 
following drugs has increased, decreased, or stayed the same. 
 
Alcohol: Increased          Decreased The Same 
 
Benzo's:      Increased          Decreased    The Same 
 
Cocaine:        Increased          Decreased        The Same 
 
Hash:              Increased          Decreased        The Same 
 
Heroin:            Increased          Decreased        The Same 
 
Tri-Cyclics:     Increased          Decreased        The Same 
 
Other___________________:  Increased         Decreased       The Same 
 
 
 29
 
 
 
 
 
Appendix 2 
 
Case Studies8 
 
Case Study 1 
 
“I was released from James’s Hospital after I injected contaminated heroin two weeks 
previously. I was on 120mls of Methadone when I was discharged. I was sent to Trinity 
Court where I hoped to be taken on in the fourth floor clinic. Instead I was taken on in the 
first floor9 which I knew was a bad start. At this stage I was still very sick, weak, and in a lot 
of pain. They started me off on 50mls of Methadone and said they would bring me up to a 
higher dose if my urines got clean, which I find ridiculous because there is no need to 
increase the dose if you can clean your urines on 50mls. 
 
However considering the condition I was in, 50 mls was not enough. I went into severe 
withdrawals which I could only relieve by taking heroin or extra Methadone and I told my 
doctor about this. The response was to reduce my dose which only made matters worse as 
I was now completely unable to manage on the dose they were giving me. I went in to see 
the doctor again to ask if they were aware of where I came from and of my condition. He 
made it clear they were well informed of my background and that it made no difference.  
 
The next thing he did was to cut my dose even further. At this stage I realised I was going 
nowhere and it was only a matter of time before I was cut off. At this stage I was falling 
apart and I was back to square one. A few days later I was called into the doctors and I was 
told I was knocked off and put on the Night Train.10 Now I am back to zero again – using, 
abusing, and going downhill fast.  
 
I feel that from day one I was never given a chance. It seems as if they just made their 
minds up that I wasn’t worth the trouble and gave me no help whatsoever. I was in and out 
the other side within the space of three weeks”. 
 
 
Case Study 2 
 
 
John was with a Health Board satellite clinic for three years. He was on a Methadone 
maintenance programme of 65ml per day and Zimmovane11 at night. He was using Valium 
which he purchased from the streets. He informed his doctor of this a long time ago. John 
                                                 
8 All names have been changed. 
9 Two separate treatment programmes operate in the National Drug Treatment Board. Service users often differentiate 
these programmes by referring to them as the “Ground Floor” (or “First Floor”) and the 
 “Fourth Floor”. 
10 The Night Train is the late afternoon programme in Trinity Court which only prescribes 20mls and assumes that 
people are also using heroin. 
11 Traditionally prescribed as a sleeping tablet. 
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said he never had any particular problems with the clinic before. His problems began in the 
middle of August 2000. 
 
Week 1:  
Monday: John gave a urine which was supervised by a G.A.12 The G.A. told him it was 
clean as it was ‘tested on the spot’. The doctor (who was a stand in for his regular doctor) 
called John and informed him that his urine had heroin in it. John’s take-away was stopped 
immediately. John claims his urine had no heroin in it as he had not used. 
Tuesday:  John went to the clinic for his Methadone, got his medicine and left. 
Wednesday:  John went to the clinic for his Methadone, saw his own doctor and was given 
back his take-aways. 
 
Week 2: 
John gave a urine. It was again ‘tested on the spot’. The G.A. told John that it was clean. 
Again the doctor (who was a stand in) said there was a slight bit of heroin in it. John went to 
the G.A. and told him what was happening. The G.A. rang the doctor and told him he 
believed the urine was clean. John’s take-aways were stopped again. 
The following day John’s take-aways were given back by his own doctor. He had also gone 
to see a solicitor about the treatment he was receiving in the clinic. A nurse who dispenses 
the Methadone told John he had 12 months of clean urines. 
 
Week 3: 
Monday:  John gave a urine. It was clean and he got his take-aways and left. 
Wednesday:  John wasn’t due to go to the clinic himself but he went in with a long time 
friend. John’s doctor told John to leave. He left. On Thursday he went to the clinic, gave a 
urine and he was told it was clean. He was then called in to see his doctor and was told he 
was having no more take-aways. John asked why and was told that as he was coming to 
the clinic so often at non designated times with friends, it was clear that he could attend 
every day himself to collect his Methadone. John explained how awkward it would be and 
he was told he should have thought of that before. John began to get verbally aggressive 
and tried to stick up for himself. He also pointed out the mistakes of his urine testing. He 
was told to come back the next day.  A week or two later he came back to state he was on 
the Methadone bus, using heroin every day, robbing daily and having problems with his 
partner. He said he had met with the ‘top man’ (a Consultant) and was reassured by him 
that his case would be dealt with by him. The Consultant made arrangements to see him in 
10 days.  John had hopes of a stabilised lifestyle. 
 
 
 
 
Case Study 3 
 
“I have been years on maintenance. I was going to Pearse Street even as far back as when 
Jervis Street treated drug users. I was controlled for years. I say controlled because of the 
facts. When I was on Physeptone I was on 100mls. When they changed to green I was put 
up to 150mls. Over the years I was grand on the brown. Every so often I would feel a bit 
sick but it did not last too long so I never bothered having my dose raised while I was on 
the brown. But the green is another story. I am more often sick on this than well. It makes 
you very frustrated. The only way I can describe it is there is something missing but you 
                                                 
12 GA is a General Assistant in a Clinic; usually they have door and urine supervision responsibilities. 
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don’t know what it is. I was never on tablets but I even got myself into trouble with them. I 
think it was because I was looking for what I was missing. I am trying to stay off the tablets 
now. I am just taking them to sleep. I take two at night after over a year or more taking 10 
to 15 a day. I am back stable now. I was scripted out to a doctor about six months ago. At 
first I was delighted but now I hate it. The doctor is treating me like a child. I have two 
grandchildren. I am not a child. I have been an addict for many years now. After being so 
controlled I can honestly say I am in control of myself. I know when I am in danger. I can 
pull myself together when I need to. The chemist I go to is always leaving me short at least 
20mls. When it first happened I was explaining that by measuring out each dose up to 
60mls they were not allowing for what was left in the measure. I said take 80mls out of the 
500mls bottle, give me 60mls and seal the bottle. That would make it exactly right. The 
chemist fellow said to me that there was no more than 500mls in the 500mls bottle. I said if 
it was a little over it was to allow for spillage and for measuring with a small cup and it was 
better to have more than less. The next time I was left short it was two weeks later and 
when I complained they gave me a contract to sign”. 
 
 
Case Study 4 
 
On his release from prison, Mark went on a Methadone programme in his community. The 
mother of his children is also a heroin addict. He felt he was doing fine and had gained 
access to see his children every weekend. Mark did not have any problems and was 
working on and off for about two years. In the first year things started to go wrong for him. 
His partner was charged with Grievous Bodily Harm and got a three year sentence. She is 
now in Mountjoy. Both children are now in the custody of their maternal grandparents. They 
refused Mark access to see his children and when he tried to get the family home in order 
to get full access of his children the council refused him as he had not lived there for the 
last two years. 
 
Mark got very depressed and was drinking a lot. He also had a few run-ins with the clinic. 
He felt his Methadone was not holding him. When he asked his doctor to up his dose he 
was refused and was told drink was the reason his Methadone was not holding him. Five 
months ago Mark started using heroin again as he was very stressed. He gave three dirty 
urines over a period of six weeks. His doctor then told him he was cutting his Methadone 
down to 20mls a day within a week, that was 10mls per day. This was to teach him a 
lesson. The doctor will review his case in two months. Mark has to use heroin every day as 
he was dropped from 80mls to 20mls daily and was experiencing severe methadone 
withdrawals. 
 
Within those two months he was spending up to £100 per day on heroin. This caused him a 
lot of problems with his family and also with his community. He has built up a debt of £2000 
and feels that everything he worked for in the past two years was destroyed in two months. 
He got back on his programme two weeks before this interview but feels very bitter and 
angry that the doctor had such power over his life. 
 
 
Case Study 5: 
 
 32
“Before the Protocol I had been on with a GP. I was prescribed three Valium 5mg, two 
Rohypnol13 and 150mls of Physeptone per day. I visited the doctor once a week and gave 
my urine with the door open. I got a week’s script at a time until the protocol. First I went to 
Trinity Court and then to the fourth floor14 and was given 60mgs per day. I collected once a 
week. The change from brown to green was extremely difficult. Not just the volume of 
liquid. My chest cough got worse and irritating. If I could have collected my Methadone 
earlier I would have; it wasn’t holding me. With the brown I could wait a couple of hours but 
with the green I needed it immediately. Phy-meth is better. Both Pinewood and Martindale 
changes from batch to batch and chemist to chemist. There is no consistency. Pinewood 
and Martindale don’t register. They are too gradual. No effect and they are shorter acting. 
The green didn’t hold me. I was increased to 80mls and had to collect twice weekly. I was 
buying more on the street and was actually taking 90mls every day. I started taking Valium 
more often. I moved to a clinic in Rathmines and had to attend in the evening twice a week. 
Due to the complaints of residents the clinic switched to mornings – 7.30am to 8.30am. I 
was cut down to 70mls, then put up to 80mls, then put back down to 70mls. My father went 
to the doctor and I was upped again to 80mls and then eventually to 90mls. After three 
months I was told, “Stop taking Valium and start taking Zimmovane”. The doctor gave me 
more Zimmos and more Methadone. Shortly after I was cut by 20mls for giving a “dirty” 
urine. I started taking Valium again and scoring gear to compensate.  
 
I wanted to go to the hospital for a break from the pressure but I got no assistance from the 
clinic. I went to another GP and told him I was afraid of having a breakdown. The only 
referral he would give was for a detox but I wanted respite. The doctor said there are plenty 
of services for users but he didn’t know of any. Since then my Dad spoke to the doctor. I 
was upped to 90mls on condition of clean urines. This meant no opiates. Valium is okay 
and I have to give two urines a week. I have very little say in my life as regards health 
issues. Someone with a minor health problem would get better treatment. All of my 
symptoms are dismissed. Everything is put down to drug taking. When I am talking to the 
doctor people in the waiting room can hear. I feel I can’t speak to the doctor about 
treatment or anything else. A patient has to be there on time but the doctor doesn’t. I am 
afraid to go to the toilet before going to the doctor. If I can’t give a sample it is marked as 
dirty. 
 
I had a good relationship with my GP. He treated me like a person. I missed that. If there 
were problems with the chemist he would sort them out, tell you about new forms of 
treatment, ask your opinion on what can be done and ask about your general health. When 
I was with him I had anonymity. I was going to a doctor and a chemist in an area where I 
didn’t live. Only my friends knew I was on Phy. Now everybody in the area knows what is 
going on. Neighbours stare at me when I am drinking my methadone in the chemist. I have 
no privacy at all. The chemist doesn’t like me drinking it there either.  
 
The dole suggested I go on Disability Allowance. They said that unless I stopped taking 
Methadone I would be considered unfit for work. I am afraid to stop taking Methadone in 
case I relapse and couldn’t get back on a clinic”. 
 
 
 
 
 
                                                 
13 Traditionally prescribed as a sleeping tablet. 
14A programme located in the National Drug Treatment Board. 
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Case Study 6: 
 
“I was on Pearse Street and was on a maintenance of 40mgs brown. I was tried out on five 
or six anti-depressants – none of which worked. I stayed on that for five years and was 
upped to 60mls of green. Two years ago I started taking benzos. They helped me cope; it 
wasn’t for a hit. The benzos kept turning up in the urine. With brown I was able to hold it 
together. The green was not as satisfying. The clinic had cut me 10mls because of the 
benzos. I’d clean up for a week or two; then the methadone would be upped. Then benzos 
would turn up again and I would be cut again. Seven or eight months ago it was suggested 
I go to Beaumont to detox from benzos. I had too many personal problems and felt I wasn’t 
ready. But eight weeks ago I went to Beaumont for two and a half weeks. I was put on four 
Ativan15 for five days and then cut to three and then cut to one pill every three days. Three 
days later I was discharged. They thought I had done well but I did not feel strong enough. I 
felt very vulnerable. I knew I had to face personal circumstances again and I was not 
prepared. They didn’t prepare me for coming out. When I went into Beaumont I was on four 
take-aways a week and was on the first card16. I thought if I fucked up I would be on a first 
warning. After a week they stopped giving Zimmovane to everyone except those on 
combination therapy. I was getting two Zimmovane per night from my GP since 1997 and 
the clinic put me on them in 1999. I refused to take my Methadone and asked to see Dr. 
(name). He offered to raise my Methadone which I refused. He wouldn’t give me 
Zimmovane and he offered me Melleril17 which I also refused. The next day I tested positive 
for benzos and was given a red card. I was told to clean up my act in three weeks or else. I 
feel I need to be prescribed a small amount of benzos. I really can’t function without them. I 
am very anxious and worried about the future. If I am put on the night train I feel I might 
start using gear again or worse. 
  
 
 
15 Traditionally prescribed for anxiety. 
16 Some drug treatment clinics operate a card warning system, yellow and red. 
17 Traditionally prescribed for psychoses.  
